Oncology Medical Payer Strategy Director (Hybrid)

AbbVie; Florham Park (NJ); Hybrid; USD 180,000 - 260,000; Full time

Job summary

AbbVie is seeking a Scientific Director to provide medical and scientific input into medical market access strategies for oncology, working across payer groups, HCMDMs, and health systems. You will shape value narratives using clinical and real-world data, and collaborate with commercial, HEOR and medical affairs teams to support portfolio strategies.

The role requires leading cross-functional sub-teams, developing integrated evidence plans, and monitoring global healthcare policy trends.

Qualifications

• Excellent oral and written communication skills; ability to present complex data clearly.
• Ability to interact with cross-functional teams and external stakeholders.
• Experience with pharmacoeconomics, health outcomes data, or RWE is a plus.
• International experience is a plus and can support global strategy.

Responsibilities

• Lead development of medical affairs payer/HCDM strategy for the assigned therapeutic area and assets.
• Translate clinical, economic, humanistic and real-world evidence into a differentiated value narrative.
• Provide medical, scientific, pharmaeconomic, and healthcare landscape input into portfolio plans.
• Lead training for Medical Outcomes Science Liaison teams.
• Collaborate with Medical Affairs and HEOR to develop an integrated evidence plan.

Skills

Oral & written communication

Cross-functional collaboration

Statistical methodology knowledge

International experience

Education

PhD/PharmD/PA/NP

Residency or postdoc preferred

Job description

AbbVie is seeking a Scientific Director to provide medical and scientific input into medical market access strategies for oncology, working across payer groups, HCMDMs, and health systems. You will shape value narratives using clinical and real-world data, and collaborate with commercial, HEOR and medical affairs teams to support portfolio strategies.

The role requires leading cross-functional sub-teams, developing integrated evidence plans, and monitoring global healthcare policy trends.